liquid chromatography

OTHER19 trials

Sponsors

NCIC Clinical Trials Group, City of Hope Medical Center, Wake Forest University Health Sciences, Vanderbilt-Ingram Cancer Center, Cancer Research UK

Conditions

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic OligoastrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaAdult Mixed Glioma

Early Phase 1

Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery

CompletedNCT00601913

Wake Forest University Health SciencesHead and Neck Cancer

Start: 2008-03-31End: 2014-10-31Updated: 2018-07-05

Phase 1

SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

CompletedNCT00504296

NCIC Clinical Trials GroupUnspecified Adult Solid Tumor, Protocol Specific

Start: 2007-09-14End: 2011-06-21Updated: 2023-08-04

Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction

CompletedNCT00540982

City of Hope Medical CenterLung Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Start: 1997-02-20End: 2010-05-20Updated: 2025-07-02

Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors

CompletedNCT00547131

City of Hope Medical CenterBrain and Central Nervous System Tumors, Metastatic Cancer

Start: 2006-01-31End: 2009-05-31Target: 12Updated: 2018-04-17

Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

CompletedNCT00645710

City of Hope Medical CenterLiver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer +2

Start: 2005-02-11End: 2018-02-07Updated: 2019-03-28

Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases

WithdrawnNCT00738335

University of California, San FranciscoLung Cancer, Metastatic Cancer

Start: 2009-01-31End: 2009-07-31Updated: 2012-10-04

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

CompletedNCT00753207

Cancer Trials IrelandBreast Cancer

Start: 2007-10-31End: 2012-03-31Updated: 2016-02-15

Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity

CompletedNCT00825201

City of Hope Medical CenterOvarian Cancer, Peritoneal Cavity Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Start: 2009-01-31End: 2018-01-16Updated: 2018-01-19

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

CompletedNCT01234740

City of Hope Medical CenterAdult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligoastrocytoma +7

Start: 2010-12-31End: 2013-03-31Updated: 2018-04-17

Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

TerminatedNCT01582009

Roswell Park Cancer InstituteClear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer +1

Start: 2010-03-31End: 2015-12-31Updated: 2022-08-15

Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

CompletedNCT01673217

Roswell Park Cancer InstituteRecurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer

Start: 2009-04-30End: 2013-06-30Updated: 2022-08-01

Phase 2

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

CompletedNCT00633750

Vanderbilt-Ingram Cancer CenterBreast Cancer

Start: 2002-08-31End: 2007-10-31Updated: 2012-09-05

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

CompletedNCT00664781

Cancer Research UKbrca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer +1

Start: 2007-12-31End: 2015-01-31Updated: 2016-05-24

Unknown Phase

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

TerminatedNCT00813878

City of Hope Medical CenterBreast Cancer

Start: 2001-07-31End: 2012-09-30Updated: 2017-10-13

Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers

CompletedNCT00899769

Vanderbilt University Medical CenterHead and Neck Cancer

Start: 2005-04-30Target: 100Updated: 2017-03-14

Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps

CompletedNCT00898378

Indiana UniversityColorectal Cancer, Healthy, no Evidence of Disease, Precancerous Condition

Start: 2009-01-31End: 2014-03-31Updated: 2014-09-18

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

CompletedNCT00898508

City of Hope Medical CenterBreast Cancer

Start: 2005-08-31End: 2019-06-06Updated: 2025-06-25

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

CompletedNCT01385150

Eastern Cooperative Oncology GroupLeukemia

Start: 2012-01-03End: 2012-02-03Updated: 2017-05-19

Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma

CompletedNCT01387724

Children's Oncology GroupNeuroblastoma

Start: 2011-06-30Target: 300Updated: 2016-05-18

Related Papers

Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status

Frontiers in Oncology2022-08-301 citations

Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma

Investigational New Drugs2019-10-2518 citations

A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity.

2019-01-0823 citations

A pilot study of vinorelbine safety and pharmacokinetics (PKs) in patients (pts) with varying degrees of liver dysfunction (LD).

Journal of Clinical Oncology2018-02-01

Pharmacologic advantage (PA) of intraperitoneal (IP) nab-paclitaxel in patients with advanced malignancies primarily confined to the peritoneal cavity.

Journal of Clinical Oncology2015-05-2011 citations